0
0
11/10/22 at 2:03pm
Organization
PRNewswire
31 words
0
Comments
/PRNewswire/ -- Noven Pharmaceuticals, Inc., ("Noven") a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. focusing on the development of...
You are the first to view
https://www.prnewswire.com/news-releases/noven-to-participate-in-annual-international-conference-on-adhd-chadd-301674128.html
Create an account
or login to join the discussion